theranos

WIPO WIPO 2013

Schützen Sie diese Marke vor Nachahmern!

Mit unserer Markenüberwachung werden Sie automatisch per E-Mail über Nachahmer und Trittbrettfahrer benachrichtigt.

Die Internationale Marke theranos wurde als Bildmarke am 14.12.2013 bei der Weltorganisation für geistiges Eigentum angemeldet.

Logodesign (Wiener Klassifikation)

#Briefe, die eine besondere Form des Schreibens darstellen #Buchstaben, die mit einem figurativen Element verbunden sind

Markendetails Letztes Update: 19. Oktober 2018

Markenform Bildmarke
Aktenzeichen 1215178
Länder Australien Schweiz China Israel Indien Japan Südkorea Mexiko Norwegen Philippinen Russland Singapur
Basismarke US Nr. 85960653, 14. Juni 2013
Anmeldedatum 14. Dezember 2013
Ablaufdatum 19. März 2018

Markeninhaber

1701 Page Mill Road
Palo Alto, CA 94304
US

Markenvertreter

801 California Street, Silicon Valley Center US

Waren und Dienstleistungen

01 Reagents for scientific or research use; diagnostic reagents for clinical or medical laboratory use (terms too vague in the opinion of the International Bureau - Rule 13(2)(b) of the Common Regulations); chemical preparations for scientific purposes; reagents for chemical analysis; diagnostic kits (terms too vague in the opinion of the International Bureau - Rule 13(2)(b) of the Common Regulations); testing kits containing reagents used in analyzing and detecting certain toxins for clinical or medical laboratory use; genetic identity tests comprised of reagents; antibodies for in vitro scientific or research use; biochemicals (terms too vague in the opinion of the International Bureau - Rule 13(2)(b) of the Common Regulations); biomedical compounds (terms too vague in the opinion of the International Bureau - Rule 13(2)(b) of the Common Regulations); chemical preparations to be used in biochemical and clinical research; diagnostic preparations for clinical or medical laboratory use (terms too vague in the opinion of the International Bureau - Rule 13(2)(b) of the Common Regulations)
05 Biological and chemical preparations for medical or veterinary use; reagents and media for medical or veterinary purposes; clinical medical reagents; biological and chemical preparations, namely, antibodies for clinical, medical or veterinary use to detect and analyze substances; diagnostic kits for medical or veterinary use (terms too vague in the opinion of the International Bureau - Rule 13(2)(b) of the Common Regulations); diagnostic preparations for medical or veterinary purposes; testing kits for testing bodily fluids (terms too vague in the opinion of the International Bureau - Rule 13(2)(b) of the Common Regulations); medical diagnostic test kits comprised of reagents and assays for testing of body fluids; medical diagnostic and monitoring test strips for use in the treatment of a wide variety of diseases and health disorders; test strips for medical and laboratory analysis of blood; ovulation test kits (terms too vague in the opinion of the International Bureau - Rule 13(2)(b) of the Common Regulations); biological tissue cultures for medical or veterinary purposes; culture media for cultivating blood cells
09 Computer software; computer software for medical monitoring and analysis of medical data; computer software for analysis of body fluids; computer software for communication and data transfer between health care professionals and patients; computer hardware; mobile electronic devices (terms too vague in the opinion of the International Bureau - Rule 13(2)(b) of the Common Regulations); electronic publications
10 Medical devices; medical devices, namely, point of care and handheld devices for analysis of drugs, proteins and other substances, and wireless transfer of medical data; medical measuring apparatus; medical measuring apparatus, namely, cartridges for use with therapies or equipment for medical monitoring and analysis of substances; apparatus for blood analysis; apparatus for taking blood samples; blood testing apparatus; apparatus for clinical diagnosis; capillary reagent tubes; capillary tubes for blood; capillary tubes for samples; containers especially made for processing blood samples; containers for medical waste; devices for monitoring blood sugar; diagnostic apparatus for the detection of a wide variety of diseases; health monitoring devices; medical diagnostics apparatus; medical apparatus and instruments for monitoring blood properties; medical devices for obtaining body fluid samples; patient medical monitors for monitoring a wide variety of physical conditions and diseases; home or portable monitors for monitoring a wide variety of physical conditions and diseases
35 Administering pharmacy reimbursement programs and services; administration of patient reimbursement programs; billing; compiling of information into computer databases; management and compilation of computerized databases; medical referrals (terms too vague in the opinion of the International Bureau - Rule 13(2)(b) of the Common Regulations); physician referrals (terms too vague in the opinion of the International Bureau - Rule 13(2)(b) of the Common Regulations); medical billing support services; providing an internet-based database of patient medical information designed to facilitate sharing and maintenance of patient medical information between and amongst the patient, insurers and healthcare professionals providing services to the patient; providing an internet-based system for confirming patient identity, eligibility and authorization for health insurance or medicare/medicaid services; maintaining patient medical records and files
36 Insurance claims processing; pharmaceutical benefit management services; pharmacy benefit management services; medical laboratory benefit management services
39 Biomedical services, namely, storage of medical data; biomedical services, namely, the storage of human cells for medical use; consulting services in the field of air medical operations in the nature of air medical transport; medical transport services; transportation of medical waste and special waste
42 Medical and scientific research services in the fields of blood analysis health care and health care monitoring; pharmaceutical research services; pharmaceutical research and development; blood analysis services; chemical laboratories; consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; genetic testing of laboratory animals for research purposes; biological research; biomedical research; laboratory research in the field of chemistry, biochemistry, biology, health and medicine; laboratory services, namely, pigment and color analysis; laboratory services, namely, imaging core lab services; medical laboratories (terms too vague in the opinion of the International Bureau - Rule 13(2)(b) of the Common Regulations); medical laboratory services (terms too vague in the opinion of the International Bureau - Rule 13(2)(b) of the Common Regulations); providing laboratory research services in the field of gene expression, namely, cancer biology; rental of laboratory apparatus and instruments; scientific laboratory services; providing a web site featuring technology that enables patients, physicians and other healthcare providers to generate, manage and exchange medical information (terms too vague in the opinion of the International Bureau - Rule 13(2)(b) of the Common Regulations); Software as a Service (SaaS) for medical and disease analysis
44 Medical evaluation services; medical evaluation services, namely, assessment of patients undergoing medical treatment; medical monitoring services; medical monitoring services, namely, monitoring the efficacy of therapy and total patient or consumer health; medical diagnostic testing, monitoring and reporting services; collection and preservation of human and animal blood; consulting services in the field of health; consulting services in the field of diagnostic medical testing; consulting services in the fields of health and healthcare; drug use testing services; drug, alcohol and DNA screening for medical purposes; health assessment services; health care; medical counseling; medical information; medical screening; medical services; medical testing for diagnostic or treatment purposes; providing information in the field of pet health; pet hospital services; providing a web site featuring medical information (terms too vague in the opinion of the International Bureau - Rule 13(2)(b) of the Common Regulations); providing a website featuring health and healthcare information; internet-based health care information services; providing health information; providing healthcare information; rental of medical equipment; veterinary special services; medical and veterinary services; biomedical services; advisory, consultative and telephone helpline services relating to the use of apparatus, instruments and test kits diagnostic testing, self testing, self monitoring and testing for adverse drug reactions
Die Bezeichnungen wurden automatisch übersetzt. Übersetzung anzeigen

Markenhistorie

Datum Belegnummer Bereich Eintrag
26. September 2018 2018/42 Gaz US RAW: Total Ceasing Effect
27. Juni 2018 2018/28 Gaz PH RAW: Total Invalidation
22. März 2017 2017/28 Gaz SG RAW: Rule 18ter(2)(ii) GP following a provisional refusal
10. Februar 2017 2017/13 Gaz PH RAW: Rule 18ter(2)(i) GP following a provisional refusal
04. Juli 2016 2016/46 Gaz IL RAW: Rule 18ter(2)(ii) GP following a provisional refusal
19. April 2016 2016/17 Gaz AU RAW: Rule 18ter(2)(ii) GP following a provisional refusal
07. April 2016 2016/17 Gaz JP RAW: Rule 18ter(2)(ii) GP following a provisional refusal
12. Januar 2016 2016/3 Gaz IL Ablehnung
25. Dezember 2015 2016/2 Gaz RU RAW: Rule 18ter(2)(ii) GP following a provisional refusal
16. November 2015 2015/47 Gaz KR RAW: Rule 18ter(2)(ii) GP following a provisional refusal
12. Oktober 2015 2015/42 Gaz IN Ablehnung
06. Oktober 2015 2015/43 Gaz RAW: Limitation
28. August 2015 2015/36 Gaz RU Ablehnung
31. Juli 2015 2015/32 Gaz MX Ablehnung
28. Juli 2015 2015/35 Gaz CN Ablehnung
15. Juni 2015 2015/25 Gaz CH Ablehnung
20. März 2015 2015/13 Gaz NO Ablehnung
11. März 2015 2015/13 Gaz SG Ablehnung
05. Februar 2015 2015/7 Gaz PH Ablehnung
05. Februar 2015 2015/6 Gaz JP Ablehnung
22. Januar 2015 2015/4 Gaz KR Ablehnung
07. Oktober 2014 2014/41 Gaz AU Ablehnung
14. Dezember 2013 2014/34 Gaz US Eintragung

ID: 141215178